Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $864.81 | 57 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $294.41 | 21 | $0 (2024) |
| PFIZER INC. | $176.20 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $79.11 | 5 | $0 (2024) |
| Lilly USA, LLC | $59.21 | 4 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $43.52 | 2 | $0 (2022) |
| Phathom Pharmaceuticals, Inc. | $30.79 | 2 | $0 (2024) |
| Genentech USA, Inc. | $27.61 | 5 | $0 (2021) |
| Vanda Pharmaceuticals Inc. | $24.30 | 1 | $0 (2024) |
| Abbott Laboratories | $23.74 | 1 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $21.16 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $332.28 | 22 | ABBVIE INC. ($156.05) |
| 2023 | $249.77 | 14 | PFIZER INC. ($80.32) |
| 2022 | $142.76 | 8 | Biohaven Pharmaceutical Holding Company Ltd. ($43.52) |
| 2021 | $140.00 | 13 | AbbVie Inc. ($45.73) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: PAIN | ||||||
| 09/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Inflammation | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: WOMENS HEALTH | ||||||
| 07/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: SCHIZOPHRENIA | ||||||
| 06/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.18 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.42 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: PAIN | ||||||
| 04/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Diabetes | ||||||
| 02/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: PAIN | ||||||
| 02/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.38 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: PAIN | ||||||
| 10/31/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 302 | 600 | $21,510 | $7,695 |
| 2022 | 5 | 173 | 240 | $10,077 | $3,477 |
| 2021 | 5 | 98 | 133 | $4,033 | $1,347 |
| 2020 | 6 | 193 | 297 | $12,185 | $2,935 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 85 | 141 | $11,280 | $4,479 | 39.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 71 | 115 | $1,725 | $966.00 | 56.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 31 | 104 | $4,038 | $765.35 | 19.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 20 | $1,660 | $617.12 | 37.2% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 27 | 32 | $800.00 | $518.40 | 64.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 44 | 73 | $1,095 | $248.93 | 22.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 18 | 67 | $472.00 | $60.82 | 12.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 48 | $440.04 | $39.49 | 9.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 62 | 85 | $6,800 | $2,588 | 38.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 13 | 14 | $1,162 | $465.22 | 40.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 57 | 81 | $1,215 | $231.68 | 19.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 29 | 47 | $705.00 | $161.17 | 22.9% |
| 85018 | Blood count, hemoglobin | Office | 2022 | 12 | 13 | $195.00 | $30.43 | 15.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 15 | 17 | $1,360 | $872.27 | 64.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 31 | $1,178 | $188.70 | 16.0% |
| 81002 | Urinalysis, manual test | Office | 2021 | 35 | 44 | $660.00 | $153.12 | 23.2% |
| 93005 | Routine electrocardiogram (ekg) with tracing using at least 12 leads | Office | 2021 | 20 | 22 | $550.00 | $78.20 | 14.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 17 | 19 | $285.00 | $54.36 | 19.1% |
| 87635 | Sars-cov-2 covid-19 amp prb | Office | 2020 | 18 | 18 | $1,440 | $923.58 | 64.1% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 16 | 51 | $6,050 | $714.17 | 11.8% |
| 87804 | Detection test for influenza virus | Office | 2020 | 33 | 40 | $1,600 | $650.12 | 40.6% |
| 81002 | Urinalysis, manual test | Office | 2020 | 53 | 81 | $1,215 | $279.29 | 23.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 50 | 78 | $1,155 | $229.33 | 19.9% |
| 93005 | Routine electrocardiogram (ekg) with tracing using at least 12 leads | Office | 2020 | 23 | 29 | $725.00 | $138.44 | 19.1% |
About David Mcclain, ARNP
David Mcclain, ARNP is a Family healthcare provider based in Russellville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790771954.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Mcclain, ARNP has received a total of $864.81 in payments from pharmaceutical and medical device companies, with $332.28 received in 2024. These payments were reported across 57 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($864.81).
As a Medicare-enrolled provider, Mcclain has provided services to 766 Medicare beneficiaries, totaling 1,270 services with total Medicare billing of $15,454. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Russellville, KY
- Active Since 09/23/2005
- Last Updated 08/15/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1790771954
Products in Payments
- VRAYLAR (Drug) $185.85
- NURTEC ODT (Drug) $133.92
- UBRELVY (Drug) $66.92
- FARXIGA (Drug) $58.85
- PREMARIN (Drug) $43.64
- QULIPTA (Drug) $41.64
- MOUNJARO (Drug) $34.87
- VOQUEZNA (Drug) $30.79
- Xofluza (Drug) $27.61
- FANAPT (Drug) $24.30
- FREESTYLE LIBRE 2 (Device) $23.74
- Belbuca (Drug) $21.16
- INGREZZA (Drug) $20.59
- BREZTRI (Drug) $20.26
- Kcentra (Biological) $17.71
- KEVEYIS (Drug) $17.06
- PAXLOVID (Drug) $16.90
- Otezla (Drug) $14.71
- Myrbetriq (Drug) $14.69
- COLOGUARD DNA CAPTURE REAGENTS (Device) $12.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Russellville
Mrs. Melanie Malone, Crnp, CRNP
Family — Payments: $8,263
John Rice, Aprn, APRN
Family — Payments: $5,426
Amy Webster, Aprn, APRN
Family — Payments: $3,082
Jena Hamm, Crnp, CRNP
Family — Payments: $2,789
Erinn Basista, Dnp, Aprn, Fnp-C, DNP, APRN, FNP-C
Family — Payments: $2,566
Jessica Mcneese, Apn, APN
Family — Payments: $2,465